Quantum Biopharma (QNTM) Change in Acquisitions & Divestments (2020 - 2025)

Quantum Biopharma (QNTM) reported Change in Acquisitions & Divestments of $2217.0 for Q3 2025, down 99.81% sequentially from $1.2 million in Q1 2025.

Quantum Biopharma (QNTM) Change in Acquisitions & Divestments (2020 - 2025) Analysis & Trends

Quantum Biopharma (QNTM) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $2217.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Quantum Biopharma 13.11 Bn 13.10 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2025 2,217.00
Sep 30, 2025 2,217.00
Mar 31, 2025 1.18 Mn
Mar 31, 2025 1.18 Mn
Jun 30, 2024 738,000.00
Jun 30, 2024 738,000.00
Sep 30, 2023 443,138.00
Sep 30, 2023 443,138.00
Mar 31, 2022 158,036.00
Mar 31, 2022 158,036.00
Sep 30, 2020 104,872.46
Sep 30, 2020 104,872.46
Jun 30, 2020 524,338.35
Jun 30, 2020 524,338.35
Mar 31, 2020 5.78 Mn
Mar 31, 2020 5.78 Mn